Navigating new territory in targeted oncology
Ikena® is redefining the targeted oncology landscape and envisions a world in which every cancer patient has a cure.
The Ikena Approach
We develop differentiated targeted oncology therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. Our ever-growing depth of institutional knowledge and breadth of tools enable us to efficiently develop the right drug using the right modality for the right patient.
Our Pipeline
We are advancing a focused pipeline of novel biomarker-driven targeted cancer therapies. Our programs are built on robust translational research and are optimized for specific patient populations with high unmet needs.
